drugset / Trial / NCT06336603
A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
NaSingle-groupOpen-labelTreatment
Summary
Winlevi is the first topical anti androgen and sebum inhibitor approved for acne vulgaris. There is no study assessing Winlevi in combination treatment for acne .Therefore this study assesses Winlevi with Adapalene 0.3% gel in combination to emulate real life practice.
Timeline
- Start
- 2023-11-15
- Primary completion
- 2024-10-29
- Completion
- 2024-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adapalene | Other / unclassified | 0.3 % | Topical |
| Subject | Clascoterone | Small molecule | 1 % | Topical |